PRPH2 and Associated Retinal Diseases (PARD) Science Award Grant
Funding Amount
Up to US $500,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Geography
- Applicants who are not U.S. citizens and reside and work outside the U.S. may apply.
Other requirements
- Applicants must hold a Ph.
- D., M.D., D.M.D., D.V.M., D.O., O.D., or equivalent degree.
- Must hold a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory.
- Application is not limited to the U.S. or U.S. citizens.
Not eligible / not funded
- Not eligible: Purchase of capital equipment is generally not supported by the FFB.
- Not eligible: FFB does not pay any indirect or overhead charges, nor does the Foundation provide support for construction or renovation costs.
Overview
The Nixon Visions Foundation, in partnership with the Foundation Fighting Blindness, is offering the PRPH2 and Associated Retinal Diseases Science Award to support innovative research aimed at understanding PRPH2 biology in retinal diseases. With funding of up to $500,000 over one to three years, applicants are encouraged to focus on fundamental biology, disease modeling, and therapeutic approaches. This opportunity is open to qualified researchers worldwide, promoting diversity and inclusion in the scientific community.
The Nixon Visions Foundation, in collaboration with the Foundation Fighting Blindness, has committed funding to advance research towards potential treatments for PRPH2-associated retinal diseases. The Foundation Fighting Blindness will make awards for meritorious research proposals that advance our understanding of the biology and pathophysiology of PRPH2 in the retina. The award is up to $500,000, dispersed over one to three years.
The Foundation will make awards for meritorious research proposals thatadvance our understanding of the biology and pathophysiology of PRPH2in the retina. To address gaps in knowledge, proposals that focus on the following topics are strongly encouraged:
Fundamental PRPH2 biology and biochemistry, including, but not limited to:PRPH2 protein-protein interactions The differential role(s) of PRPH2 in rod and cone photoreceptorsDevelopment of high throughput and/or saturation assays to determine the functional consequences of PRPH2 variants on protein structure and/or function and to assign pathogenicity.Generation and characterization of disease models (e.g., large animals) that recapitulate PRPH2-associated human disease, including maculopathies.Studies demonstrating proof-of-concept for therapeutic approaches, particularly mutation-agnostic approaches.Improved understanding of disease heterogeneity, through understanding of genotype-phenotype relationships or identification of genetic and/or environmental modifiers.
Eligibility
Applicants must hold a Ph.D., M.D., D.M.D., D.V.M., D.O., O.D., or equivalent degree.Must hold a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory. Application is not limited to the U.S. or U.S. citizens. Applicants who are not U.S. citizens and reside and work outside the U.S. may apply.
Ineligibility
Purchase of capital equipment is generally not supported by the FFB. FFB does not pay any indirect or overhead charges, nor does the Foundation provide support for construction or renovation costs.
What The Foundation Fighting Blindness Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 38
- Total given
- $19.66M
- Median grant
- $200K
- Range
- $25K–$8.77M
- By dollars: Maryland 46%, Pennsylvania 9%, California 8%. Top recipient cities: Boston, MA; New York, NY; Houston, TX.
- 0% of grants with a stated purpose were for general or operating support.
- 16% of recipients were new grantees, not repeat recipients.
Example grants
Foundation Fighting Blindness Rd Fund · Columbia, MD
Research
$8.77M
University of Pennsylvania · Philadelphia, PA
Research
$1.4M
University of California Irvine · Irvine, CA
Research
$915K
Duke University Medical Center · Durham, NC
Research
$900K
Odylia Therapeutics · Atlanta, GA
Research
$631K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
PARD Science Awards Grant
The Foundation Fighting Blindness Inc
Amount
Up to US $500,000
Deadline
Deadline not published
Research Core Award: Non-rodent Large Animal Award
The Foundation Fighting Blindness Inc
Amount
Varies
Deadline
Deadline not published
Career Development Program (CDA) Grant
The Foundation Fighting Blindness Inc
Amount
US $375,000
Deadline
Deadline not published
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,650,000 total
Deadline
October 22, 2026
ROSES 2025: C.2 Solar System Science
NASA Headquarters
Amount
Varies
Deadline
November 12, 2026
Ready to apply for PRPH2 and Associated Retinal Diseases (PARD) Science Award Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found PRPH2 and Associated Retinal Diseases (PARD) Science Award Grant. Now let's win it.